IGC Pharma Inc (IGC)
0.3561
0.00 (0.00%)
USD |
NYAM |
Nov 22, 13:59
IGC Pharma Shareholders Equity (Quarterly): 7.377M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 7.377M |
| June 30, 2024 | 7.88M |
| March 31, 2024 | 7.321M |
| December 31, 2023 | 9.053M |
| September 30, 2023 | 14.10M |
| June 30, 2023 | 13.20M |
| March 31, 2023 | 14.91M |
| December 31, 2022 | 18.32M |
| September 30, 2022 | 20.14M |
| June 30, 2022 | 22.04M |
| March 31, 2022 | 23.89M |
| December 31, 2021 | 29.48M |
| September 30, 2021 | 31.26M |
| June 30, 2021 | 31.74M |
| March 31, 2021 | 32.80M |
| December 31, 2020 | 21.47M |
| September 30, 2020 | 23.60M |
| June 30, 2020 | 24.86M |
| March 31, 2020 | 26.54M |
| December 31, 2019 | 29.79M |
| September 30, 2019 | 31.24M |
| June 30, 2019 | 32.42M |
| March 31, 2019 | 33.57M |
| December 31, 2018 | 36.56M |
| September 30, 2018 | 13.81M |
| Date | Value |
|---|---|
| June 30, 2018 | 7.577M |
| March 31, 2018 | 8.065M |
| December 31, 2017 | 7.484M |
| September 30, 2017 | 6.230M |
| June 30, 2017 | 6.104M |
| March 31, 2017 | 7.359M |
| December 31, 2016 | 7.549M |
| September 30, 2016 | 14.40M |
| June 30, 2016 | 13.10M |
| March 31, 2016 | 13.48M |
| December 31, 2015 | 13.09M |
| September 30, 2015 | 13.57M |
| June 30, 2015 | 13.98M |
| March 31, 2015 | 14.23M |
| December 31, 2014 | 15.74M |
| September 30, 2014 | 15.36M |
| June 30, 2014 | 16.25M |
| March 31, 2014 | 13.63M |
| December 31, 2013 | 13.75M |
| September 30, 2013 | 13.93M |
| June 30, 2013 | 13.92M |
| March 31, 2013 | 14.44M |
| December 31, 2012 | 14.56M |
| September 30, 2012 | 14.24M |
| June 30, 2012 | 14.46M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
7.321M
Minimum
Mar 2024
32.80M
Maximum
Mar 2021
20.49M
Average
21.76M
Median
Shareholders Equity (Quarterly) Benchmarks
| CEL-SCI Corp | 8.473M |
| AIM ImmunoTech Inc | 2.912M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Protalix BioTherapeutics Inc | 32.44M |
| Palatin Technologies Inc | -7.686M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.37M |
| Total Liabilities (Quarterly) | 2.992M |
| Debt to Equity Ratio | 0.0183 |
| Current Ratio | 1.517 |
| Net Debt Paydown Yield | 0.00% |